[go: up one dir, main page]

EP0804547A4 - Unique associated kaposi's sarcoma virus sequences and uses thereof - Google Patents

Unique associated kaposi's sarcoma virus sequences and uses thereof

Info

Publication number
EP0804547A4
EP0804547A4 EP95929471A EP95929471A EP0804547A4 EP 0804547 A4 EP0804547 A4 EP 0804547A4 EP 95929471 A EP95929471 A EP 95929471A EP 95929471 A EP95929471 A EP 95929471A EP 0804547 A4 EP0804547 A4 EP 0804547A4
Authority
EP
European Patent Office
Prior art keywords
sarcoma virus
virus sequences
unique associated
associated kaposi
kaposi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95929471A
Other languages
German (de)
French (fr)
Other versions
EP0804547A1 (en
Inventor
Yuan Chang
Patrick S Moore
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Columbia University in the City of New York
Original Assignee
Columbia University in the City of New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/343,101 external-priority patent/US5830759A/en
Priority claimed from US08/420,235 external-priority patent/US5801042A/en
Application filed by Columbia University in the City of New York filed Critical Columbia University in the City of New York
Publication of EP0804547A1 publication Critical patent/EP0804547A1/en
Publication of EP0804547A4 publication Critical patent/EP0804547A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/245Herpetoviridae, e.g. herpes simplex virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16211Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16411Rhadinovirus, e.g. human herpesvirus 8
    • C12N2710/16422New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16411Rhadinovirus, e.g. human herpesvirus 8
    • C12N2710/16434Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP95929471A 1994-08-18 1995-08-11 Unique associated kaposi's sarcoma virus sequences and uses thereof Withdrawn EP0804547A4 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US292365 1988-12-30
US29236594A 1994-08-18 1994-08-18
US08/343,101 US5830759A (en) 1994-08-18 1994-11-21 Unique associated Kaposi's sarcoma virus sequences and uses thereof
US08/420,235 US5801042A (en) 1994-08-18 1995-04-11 Unique associated Kaposi's sarcoma virus sequences and uses thereof
US420235 1995-04-11
PCT/US1995/010194 WO1996006159A1 (en) 1994-08-18 1995-08-11 Unique associated kaposi's sarcoma virus sequences and uses thereof
US343101 1999-06-29

Publications (2)

Publication Number Publication Date
EP0804547A1 EP0804547A1 (en) 1997-11-05
EP0804547A4 true EP0804547A4 (en) 1999-11-03

Family

ID=46202761

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95929471A Withdrawn EP0804547A4 (en) 1994-08-18 1995-08-11 Unique associated kaposi's sarcoma virus sequences and uses thereof

Country Status (5)

Country Link
EP (1) EP0804547A4 (en)
JP (1) JPH10508461A (en)
AU (1) AU700913B2 (en)
CA (1) CA2196892A1 (en)
WO (1) WO1996006159A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7932066B2 (en) 1994-08-18 2011-04-26 The Trustees Of Columbia University In The City Of New York Unique associated kaposi's sarcoma virus sequences and uses thereof
US5861240A (en) * 1996-02-28 1999-01-19 The Regents Of The University Of California Isolated human herpesvirus type 8 sequences and uses thereof
TR199802421T2 (en) * 1996-05-24 1999-02-22 Biogen , Inc. Substances that regulate tissue regeneration.
US6348586B1 (en) 1996-07-25 2002-02-19 The Trustees Of Columbia University In The City Of New York Unique associated Kaposi's sarcoma virus sequences and uses thereof
WO1998004576A1 (en) * 1996-07-25 1998-02-05 The Trustees Of Columbia University In The City Of New York Unique associated kaposi's sarcoma virus sequences and uses thereof
GB9618890D0 (en) * 1996-09-10 1996-10-23 Univ Liverpool An immunogenic determinant
EP0893504B1 (en) * 1997-07-11 2003-05-14 Fleckenstein, Bernard, Prof. Dr. Polypeptide coded by the Kaposi sarcoma-associated virus (KSHV, HHV-8) and its uses in diagnostic and therapy
US6653465B2 (en) 2000-12-08 2003-11-25 The Trustees Of Columbia University In The City Of New York Spliced gene of KSHV / HHV8, its promoter and monoclonal antibodies specific for LANA2

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996015779A1 (en) * 1994-11-21 1996-05-30 The Trustees Of Columbia University In The City Of New York Unique associated kaposi's sarcoma virus sequences and uses thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996015779A1 (en) * 1994-11-21 1996-05-30 The Trustees Of Columbia University In The City Of New York Unique associated kaposi's sarcoma virus sequences and uses thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
RUSSO J J ET AL: "NUCLEOTIDE SEQUENCE OF THE KAPOSI SARCOMA-ASSOCIATED HERPESVIRUS (HHV8)", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, vol. 93, no. 25, 10 December 1996 (1996-12-10), pages 14862 - 14867, XP002027237, ISSN: 0027-8424 *
See also references of WO9606159A1 *

Also Published As

Publication number Publication date
EP0804547A1 (en) 1997-11-05
JPH10508461A (en) 1998-08-25
CA2196892A1 (en) 1996-02-29
WO1996006159A1 (en) 1996-02-29
AU3321095A (en) 1996-03-14
AU700913B2 (en) 1999-01-14

Similar Documents

Publication Publication Date Title
IL128882A0 (en) Viral vectors and their uses
HUP9802217A3 (en) Recombinant mva virus, and the use thereof
SI1019358T1 (en) 3,3-diarylpropylamines , their use and preparation
EP0891374A4 (en) Unique associated kaposi's sarcoma virus sequences and uses thereof
GB9125330D0 (en) Novel dna clones and uses thereof
EP0934333A4 (en) Unique associated kaposi's sarcoma virus sequences and uses thereof
EP0804547A4 (en) Unique associated kaposi's sarcoma virus sequences and uses thereof
AU4367096A (en) Unique associated kaposi's sarcoma virus sequences and uses thereof
IL115029A0 (en) 2,3-bridged 1,4-dihydropyridines their preparation and use
EP0832197A4 (en) Recombinant fowlpox viruses and uses thereof
HUP9600730A1 (en) 1,4-tetrazolinone-derivatives and use thereof as herbicides
NZ323282A (en) N,n'-bridged bisindolylmaleimides and their use to prepare n,n'-bridged bisindolylmaleimides
PL310820A1 (en) Heater's console
ZA955128B (en) Novel amido-quinoxalinediones the preparation and use thereof
GB9306408D0 (en) Disposable outer garments
GB9716366D0 (en) Regularly-shaped aluminosilicate and it's use
ZA95105B (en) Red-dot HIV 1 and 2
GB9509425D0 (en) "Virus"
DE69405544D1 (en) 4'-0-sulfonylanthracyclinderivate
GB9716005D0 (en) Adjustable chef's hat
GB2281211B (en) Disposable points protector
GB9309237D0 (en) Hepatitis-c virus type 4 and 6
GB9405876D0 (en) Modified virus and its use as a vector
AUPO341996A0 (en) Le chef's assistant
DE59811762D1 (en) Glycokonjugate von 20(s)-camptothecin

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19970318

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 19990921

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 6C 07H 21/04 A, 6C 12Q 1/68 B, 6C 12P 19/34 B, 6C 12N 15/10 B

17Q First examination report despatched

Effective date: 20020717

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040525